Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction

New England Journal of Medicine

Volumn 336, Issue 19, 1997, Pages 1350-1355

  Vasan, Ramachandran S ^a,c   Larson, Martin G ^a,c   Benjamin, Emelia J ^a,c   Evans, Jane C ^a   Levy, Daniel ^a,b,c,d  

^a FRAMINGHAM HEART STUDY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; FEMALE; HEART DILATATION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE WALL; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VALVULAR HEART DISEASE;

FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0031003333     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199705083361903     Document Type: Article

References (35)

1. Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Aakhus T. Heart volume and cardiovascular mortality: a 16 year follow-up study of 1984 healthy middle-aged men. Eur Heart J 1993;14:592-6.
2. Frishman WH, Nadelmann J, Ooi WL, et al. Cardiomegaly on chest x-ray: prognostic implications from a ten-year cohort study of elderly subjects: a report from the Bronx Longitudinal Aging Study. Am Heart J 1992;124:1026-30.
3. Lauer MS, Evans JC, Levy D. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol 1992;70:1180-4.
4. Hammermeister KE, Chikos PM, Fisher L, Dodge HT. Relationship of cardiothoracic ratio and plain film heart volume to late survival. Circulation 1979;59:89-95.
5. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-sysrolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
6. Galderisi M, Lauer MS, Levy D. Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (the Framingham Heart Study). Am J Cardiol 1992;70:971-6.
7. Eriksson SV, Caidahl K, Hamsten A, de Faire U, Rehnqvist N, Lindvall K. Long-term prognostic significance of M mode echocardiography in young men after myocardiaj infarction. Br Heart J 1995;74;124-30.
8. St John Sutton M, Pfeffer MA, Plappert T, et al. Quantitative twodimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril. Circulation 1994;89:68-75.
9. Kleber FX, Niemöller L, Fischer M, Doering W. Influence of severity of heart failure on the efficacy of angiotensin-converting enzyme inhibition. Am J Cardiol 1991;68:121D-126D.
10. Unverferth DV, Magorien DR, Moeschberger ML, Baker PB, Fetters JK, Leier CV. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1984;54:147-52.
11. Wong M, Johnson G, Shabetai R, et al. Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure: Veterans Affairs cooperative studies V-HeFT I and II. Circulation 1993;87:Suppf VI:VI-65-VI-70.
12. Lee TH, Hamilton MA, Stevenson LW, et al. Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 1993;72:672-6.
13. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990;81:1161-72.
14. Gaudron P, Eides C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation 1993;87:755-63,
15. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951;41:279-86.
16. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 1979;110:281-90.
17. Savage DD, Garrison RJ, Kannel WB, Anderson SJ, Feinleib M, Casrelli WP. Considerations in the use of echocardiography in epidemiology: the Framingham Study. Hypertension 1987;9:Suppl 11:11-40-11-44.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
19. Lauer MS, Larson MG, Levy D. Gender-specific reference M-mode values in adults: population-derived values with consideration of the impact of height. J Am Coll Cardiol 1995;26:1039-46.
20. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977;55:613-8.
21. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971;285:1441-6.
22. Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study: an epidemiological investigation of cardiovascular disease. Section 34. Some risk factors related to the annual incidence of cardiovascular disease and death in pooled repeated biennial measurements: Framingham Heart Study, 30-year follow-up. Bcthcsda, Md.: National Heart, Lung, and Blood Institute, 1987. (NIH publication no. 87-2703.)
23. Cox DR, Oakcs D. Analysis of survival data. London: Chapman & Hall, 1984.
24. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-83.
25. Keren A, Gottlieb S, Arbov Y, Gavish A, IMvoni D, Stern S. Usefulness of predischargc echocardiographic criteria in predicting complications following acute myocardial infarction. Cardiology 1986;73:139-46.
26. Berning J, Steensgaard-Hansen F. Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. Am J Cardiol 1990;65:567-76.
27. Caidahl K, Eriksson H, Hartford M, et al. Dyspnoea of cardiac origin in 67 year old men. 2. Relation to diastolic left ventricular function and mass: the study of men born in 1913. Br Heart J 1988;59:329-38.
28. The REG procedure. In: SAS/STAT user's guide, version 6. 4th ed. Vol. 2. Cary, N.C.: SAS Institute, 1989:1351-456.
29. SAS/STAT software: changes and enhancements, through release 6.11. Cary, N.C.: SAS Institute, 1996:381-490, 807-84.
30. Linzbach AJ. Heart failure from the point of view of quantitative anatomy. Am J Cardiol 1960;5:370-82.
31. Cohn JN. Structural basis of heart failure: ventricular remodeling and its pharmacologic inhibition. Circulation 1995;91:2504-7
32. Gaudron P, Eilles C, ErtI G, Kochsiek K. Compensatory and noncompensatory left ventricular dilatation after myocardial infarction: time course and hemodynamic consequences at rest and during exercise. Am Heart J 1992;123:377-85.
33. Jacob R, Gülch RW. Functional significance of ventricular dilatation: reconsideration of Linzbach's concept of chronic heart failure. Basic Res Cardiol 1988;83:461-75.
34. Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 1976;18:255-64.
35. Greenberg B, Quinones MA, Koilpillai C, et al. Effects of long-term enalapril therapy on cardiac structure and fonction in patients with left ventricular dysfunction: results of the SOLVD echocardiographic substudy. Circulation 1995;91:2573-81.